AINewsnow

Catch the Risk Before the First Dose - Building an AI Drug Safety Reviewer That Remembers

💡 In one line: I built TrialSleuth AI , an agent that reviews a new drug before its first human trial and remembers every past drug result, so it gets smarter with each one. 🚀 Try the live demo · 💻 See the code 🧪 The first dose is the scariest moment Every new medicine eventually reaches a day…

Read the full story at DEV Community — Machine Learning ↗

Timeline · 1 report

  1. 2026-11-08 05:53 · DEV Community — Machine Learning
    Catch the Risk Before the First Dose - Building an AI Drug Safety Reviewer That Remembers

More stories

  1. Election backlash against data centers rattles AI stocks and expansion plans — TechCrunch AI
  2. Anthropic strikes $3.4bn deal for gas-fired generators to power AI data centres — Financial Times AI
  3. OpenAI to keep expanding AI data centers despite election results favoring restrictions — DigiTimes Asia
  4. Tencent AI chief warns AI will soon master biology, raising new safety risks — SCMP China Tech
  5. Hydra-PSIE expands 'Coeziune OM–IA' DOI registry to 39 published works — DEV Community — AI
  6. Developer's 48-Hour Field Notes Detail Free-Tier LLM Batch Job Failures — DEV Community — AI
  7. Apple's John Ternus reportedly pushing for faster AI progress beyond Siri upgrades — Techmeme
  8. US AI Safety Center Staff Now Report to White House, Raising Independence Concerns — AP News

Get the daily brief of stories like this at 6:30 every morning →